This page lists the SEC filings reported by KINGDON CAPITAL MANAGEMENT, L.L.C..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2018-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Jaguar Health, Inc. | 5,462,248 | 5.8% | EDGAR |
| SC 13G/A | 2018-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | HERON THERAPEUTICS, INC. /DE/ | 2,179,620 | 3.4% | EDGAR |
| SC 13G/A | 2018-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | FATE THERAPEUTICS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2018-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | AIT Therapeutics, Inc. | 500,001 | 7.8% | EDGAR |
| SC 13G/A | 2018-01-02 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 18,846,905 | 12.0% | EDGAR |
| SC 13G/A | 2017-12-21 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 18,587,783 | 11.9% | EDGAR |
| SC 13G/A | 2017-02-17 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 7,052,800 | 6.1% | EDGAR |
| SC 13G/A | 2017-02-15 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Jaguar Animal Health, Inc. | 1,297,815 | 9.3% | EDGAR |
| SC 13G/A | 2017-02-15 | KINGDON CAPITAL MANAGEMENT, L.L.C. | FATE THERAPEUTICS INC | 2,615,847 | 7.7% | EDGAR |
| SC 13G/A | 2017-02-15 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Applied Minerals, Inc. | 5,572,882 | 4.9% | EDGAR |
| SC 13G/A | 2017-02-15 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Great Elm Capital Group, Inc. | 1,269,197 | 5.9% | EDGAR |
| SC 13G | 2017-02-15 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Horizon Pharma plc | 12,748,199 | 7.8% | EDGAR |
| SC 13G/A | 2017-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Tonix Pharmaceuticals Holding Corp. | 696,455 | 1.8% | EDGAR |
| SC 13G/A | 2017-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Dipexium Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2017-02-14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | HERON THERAPEUTICS, INC. /DE/ | 3,848,161 | 9.8% | EDGAR |
| SC 13G/A | 2016-02-16 | KINGDON CAPITAL MANAGEMENT, L.L.C. | HERON THERAPEUTICS, INC. /DE/ | 1,669,029 | 4.6% | EDGAR |
| SC 13G/A | 2016-02-16 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Vanda Pharmaceuticals Inc. | 934,568 | 2.2% | EDGAR |
| SC 13G/A | 2016-02-16 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Horizon Pharma plc | 4,776,229 | 3.0% | EDGAR |
| SC 13G/A | 2016-02-16 | KINGDON CAPITAL MANAGEMENT, L.L.C. | FATE THERAPEUTICS INC | 2,596,489 | 9.0% | EDGAR |
| SC 13G/A | 2016-02-16 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Dipexium Pharmaceuticals, Inc. | 975,099 | 9.5% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.